Skip to main content

telmisartan

Generic: TELMISARTAN·Brand: MICARDIS, Micardis, Micardis-HCT, Semintra, TELMISARTAN, Twynsta, Widaplik

telmisartan: 2 clinical trials tracked.

telmisartan evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about telmisartan, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Prostate Cancer

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

Edmond J Safra, Accelerating Clinical Trials in Parkinson's Disease (EJS ACT-PD) - a Multi-arm Multi-stage Platform Trial for Potential Disease Modifying Approaches.

NCT07207057Registry updated 2025-10-03·Phase 3
Recruiting

Primary endpoint: Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I and II combined

InterventionalRandomizedquadruple1,200 targetStarted 2025-09Completion 2031-072 sites · United KingdomUniversity College, London

Phase I Non-Randomized, Unblinded, Single-Center Trial of Oral Telmisartan Alone or Combined With Selected Standard of Care Therapies for Prostate Cancer

NCT06168487Registry updated 2025-08-21·Phase 1
Recruiting

Primary endpoint: Tolerability of oral telmisartan

Interventionalopen36 targetStarted 2024-04Completion 2027-041 site · United StatesTyler J Curiel